Scientists Turned an 80-Year-Old's Blood Cells Into a Brain 60 Years Younger

A Biological Clock Running Backward

In a 2026 study published in Aging Cell, researchers at the University of Bonn converted blood-cell precursors from an 80-year-old donor into neural stem cells with an epigenetic age below 20. Read that again: cells taken from an octogenarian were transformed into brain stem cells that behaved — molecularly, functionally, measurably — like those of a teenager. And the most stunning part? Over the following 50 to 100 days, they kept de-aging, eventually reaching about 5 percent of the donor's age. Counter-intuitively, they got younger as they got older.

Researchers from the University Hospital of Bonn and the University of Bonn succeeded in dramatically rejuvenating human cells in a test tube, directly reprogramming red blood cell precursors into stem cells from which neurons can grow. The results were published in the journal Aging Cell. The study involved an unusually wide range of human donors: researchers used cells from 15 people across the age spectrum, ranging from newborn to 101 years of age.

Skipping the Middleman

What makes this discovery especially significant is the method used to achieve it. Scientists have long been able to reprogram cells, but the standard approach is cumbersome. Cellular transformations can be done in two main ways. The first, more circuitous route turns a specific cell back into a pluripotent stem cell — an embryonic "blank slate" — and then into a different cell type. The second method involves a "direct conversion," which skips the middle stage and directly transforms a cell into a different type.

The team used erythroid progenitor cells (EPCs) — immature red blood cell precursors — from 15 donors. By delivering two transcription factors via a virus, they directly converted these blood cells into induced neural stem cells (iNSCs). Within 12 days, the cells began expressing neural-like proteins. The rejuvenation wasn't just cosmetic, either. The cells displayed less DNA damage and mitochondrial toxicity, showing that the direct conversion cells enjoyed benefits comparable to blank-slate cells.

The Surprise Was in the Slowness

Previous reprogramming methods reset a cell's age quickly — almost like flipping a switch. But the Bonn team's direct conversion approach did something different and arguably more valuable: it was slow. While a two-step pluripotent method resets aging rapidly, the direct conversion approach showed rejuvenation occurring gradually over more than 100 days. That gradual unfolding is a gift to science. The authors hope that the slow conversion could provide a window for understanding mechanisms underlying aging. "Since the epigenetic clocks are slowly reset over several weeks, we can use this model to investigate which factors and active substances accelerate or slow down the rejuvenation process," said Professor Brüstle.

The cells' epigenetic clocks were significantly reset by the reprogramming. As a result, cells from an 80-year-old subsequently exhibited a molecular age of less than 20 years. "We also know that this epigenetic rejuvenation ensures that the cells actually behave like young cells," the scientist noted. Behavior, not just appearance — that distinction matters enormously for any future therapeutic application.

What This Could Mean for Alzheimer's and Beyond

Because the converted cells can develop into nerve cells, researchers believe the approach could improve investigations into age-related neurological conditions, including Alzheimer's disease. Professor Brüstle has been direct about the stakes: "Age is the most important risk factor for neurodegenerative diseases such as Alzheimer's." A reliable laboratory model that can slowly and trackably reverse cellular aging could accelerate the search for drugs or therapies that target that risk factor at its root.

Important caveats apply. The study's authors caution against misinterpreting the findings. The experiment was conducted entirely under laboratory conditions on cultured cells. It does not mean scientists have reversed human aging. Still, the research opens a door that was previously closed. The ability to watch aging unwind — slowly, measurably, in real time — gives scientists an unprecedented tool. What they learn from that window could one day reshape how medicine approaches the diseases that rob people of their minds and memories.